The Hong Kong government has appointed a healthcare veteran to the board of the local exchange, replacing longtime banker Anita Fung.
Nisa Leung has been named by the local government to the board of the Hong Kong Exchange and Clearing (HKEX), according to a statement, for a two-year term ending in 2023.
Leung replaces longtime banker Anita Fung who boasts a rich banking career that included a role as HSBC’s Hong Kong CEO (2011-2015) and group general manager (2007-2015). Fung has also served on the HKEX board for six years.
Existing board members Rafael Gil-Tienda and Stephen Yiu have also been reappointed for an additional two-year term.
Healthcare Vet
In contrast, Leung’s background has a strong focus on the Chinese healthcare sector – a timely appointment in the midst of a coronavirus pandemic – with non-executive director roles with biopharmaceutical firm Zai Lab, heart-related medical device developer Venus MedTech, vaccine company CanSino Biologics, insulin provider Gan & Lee.
Leung is also a managing partner with Qiming Venture Partners, a Chinese venture capital firm investing in the media, internet, tech, consumer retail and healthcare sectors. She is also the daughter of Sophie Leung Lau Yau-fun, former deputy of the National People’s Congress, China’s legislature.
«[Leung’s] extensive expertise in venture capital, innovation, biotech and healthcare, and her deep knowledge of the mainland China investment market, will be immensely valuable to the board and to HKEX’s future development,” said HKEX chairman Laura Cha.
